SENSORCAINE

Sensorcaine Adverse Events Reported to the FDA Over Time

How are Sensorcaine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sensorcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sensorcaine is flagged as the suspect drug causing the adverse event.

Most Common Sensorcaine Adverse Events Reported to the FDA

What are the most common Sensorcaine adverse events reported to the FDA?

Musculoskeletal Pain	372 (4.87%)
Chondrolysis	309 (4.04%)
Joint Injury	229 (3%)
Drug Ineffective	149 (1.95%)
Hypotension	149 (1.95%)
Anaesthetic Complication	146 (1.91%)
Joint Range Of Motion Decreased	126 (1.65%)
Musculoskeletal Discomfort	112 (1.47%)
Drug Exposure During Pregnancy	101 (1.32%)
Activities Of Daily Living Impaired	100 (1.31%)
Musculoskeletal Disorder	94 (1.23%)
	Show More
Post Procedural Complication	74 (.97%)
Pain	73 (.95%)
Cardiac Arrest	59 (.77%)
Convulsion	57 (.75%)
Asthenia	52 (.68%)
Hypoaesthesia	52 (.68%)
Loss Of Consciousness	49 (.64%)
Muscular Weakness	48 (.63%)
Osteoarthritis	47 (.61%)
Vomiting	46 (.6%)
Arthropathy	44 (.58%)
Nausea	43 (.56%)
Incorrect Route Of Drug Administrat...	42 (.55%)
Bradycardia	41 (.54%)
Dyspnoea	38 (.5%)
Movement Disorder	38 (.5%)
Conjunctival Oedema	36 (.47%)
Drug Toxicity	36 (.47%)
Blood Pressure Decreased	35 (.46%)
Medication Error	35 (.46%)
Myoclonus	35 (.46%)
Arthralgia	34 (.44%)
Headache	34 (.44%)
Oxygen Saturation Decreased	34 (.44%)
Death	33 (.43%)
Fall	33 (.43%)
Synovitis	33 (.43%)
Drug Effect Decreased	32 (.42%)
Parophthalmia	32 (.42%)
Caesarean Section	31 (.41%)
Exophthalmos	31 (.41%)
Paraesthesia	31 (.41%)
Musculoskeletal Stiffness	30 (.39%)
Paraplegia	30 (.39%)
Tachycardia	30 (.39%)
Apnoea	28 (.37%)
Grand Mal Convulsion	28 (.37%)
Pain In Extremity	28 (.37%)
Rotator Cuff Syndrome	28 (.37%)
Unresponsive To Stimuli	28 (.37%)
Respiratory Distress	27 (.35%)
Agitation	26 (.34%)
Disseminated Intravascular Coagulat...	26 (.34%)
Respiratory Failure	26 (.34%)
Sensory Loss	26 (.34%)
Back Pain	25 (.33%)
Procedural Complication	25 (.33%)
Procedural Hypotension	25 (.33%)
Respiratory Depression	25 (.33%)
Disorientation	24 (.31%)
Respiratory Arrest	24 (.31%)
Visual Acuity Reduced	24 (.31%)
Dizziness	23 (.3%)
Erythema	23 (.3%)
Somnolence	23 (.3%)
Coma	22 (.29%)
Hearing Impaired	22 (.29%)
Hypertension	22 (.29%)
Hypoxia	21 (.27%)
Neuropathy Peripheral	21 (.27%)
Spinal Cord Infarction	21 (.27%)
Urinary Incontinence	21 (.27%)
Anaphylactic Reaction	20 (.26%)
Areflexia	20 (.26%)
Depressed Level Of Consciousness	20 (.26%)
Drug Interaction	20 (.26%)
Intraocular Pressure Increased	20 (.26%)
Restlessness	20 (.26%)
Urinary Retention	20 (.26%)
Wrong Drug Administered	20 (.26%)
Catheter Site Related Reaction	19 (.25%)
Overdose	19 (.25%)
Ventricular Fibrillation	19 (.25%)
Bursitis	18 (.24%)
Catheter Related Complication	18 (.24%)
Medical Device Complication	18 (.24%)
Pruritus	18 (.24%)
Staphylococcal Infection	18 (.24%)
Abdominal Pain	17 (.22%)
Cauda Equina Syndrome	17 (.22%)
Circulatory Collapse	17 (.22%)
Injury	17 (.22%)
Insomnia	17 (.22%)
Neuromuscular Block Prolonged	17 (.22%)
Pyrexia	17 (.22%)
Blood Pressure Systolic Decreased	16 (.21%)
Drug Hypersensitivity	16 (.21%)
Heart Rate Increased	16 (.21%)
Hypersensitivity	16 (.21%)
Sedation	16 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sensorcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sensorcaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sensorcaine

What are the most common Sensorcaine adverse events reported to the FDA?

Musculoskeletal And Connective Tiss...	694 (9.08%)
Neurological	533 (6.97%)
Procedural And Device Related Injur...	441 (5.77%)
Joint	377 (4.93%)
Tendon, Ligament And Cartilage	337 (4.41%)
Bone And Joint Injuries	267 (3.49%)
Therapeutic And Nontherapeutic Effe...	265 (3.47%)
Cardiac Arrhythmias	263 (3.44%)
Respiratory	263 (3.44%)
Decreased And Nonspecific Blood Pre...	186 (2.43%)
Medication Errors	170 (2.22%)
	Show More
Movement Disorders	166 (2.17%)
Chemical Injury And Poisoning	158 (2.07%)
Gastrointestinal Signs	153 (2%)
Injuries	148 (1.94%)
Cardiac And Vascular Investigations	139 (1.82%)
Lifestyle Issues	121 (1.58%)
Muscle	103 (1.35%)
Spinal Cord And Nerve Root	98 (1.28%)
Ocular Infections, Irritations And ...	97 (1.27%)
Administration Site Reactions	95 (1.24%)
Seizures	95 (1.24%)
Epidermal And Dermal Conditions	93 (1.22%)
Infections - Pathogen Unspecified	86 (1.13%)
Allergic Conditions	68 (.89%)
Vision	68 (.89%)
Peripheral Neuropathies	63 (.82%)
Anxiety Disorders	53 (.69%)
Synovial And Bursal	53 (.69%)
Urinary Tract Signs	51 (.67%)
Bacterial Infectious	49 (.64%)
Deliria	49 (.64%)
Metabolic, Nutritional And Blood Ga...	48 (.63%)
Physical Examination Topics	44 (.58%)
Ocular Structural Change, Deposit A...	41 (.54%)
Obstetric And Gynecological Therape...	40 (.52%)
Ocular Neuromuscular	40 (.52%)
Fatal Outcomes	38 (.5%)
Neurological, Special Senses And Ps...	38 (.5%)
Lower Respiratory Tract Disorders	37 (.48%)
Headaches	35 (.46%)
Hearing	35 (.46%)
Tissue	34 (.44%)
Bone Disorders	31 (.41%)
Central Nervous System Vascular	31 (.41%)
Body Temperature Conditions	28 (.37%)
Coagulopathies And Bleeding Diathes...	27 (.35%)
Eye	27 (.35%)
Product Quality Issues	27 (.35%)
Therapeutic Procedures And Supporti...	27 (.35%)
Vascular	26 (.34%)
Coronary Artery	25 (.33%)
Hematology Investigations	24 (.31%)
Vascular Hypertensive	22 (.29%)
Bronchial Disorders	21 (.27%)
Neuromuscular	21 (.27%)
Sleep Disorders	21 (.27%)
Vascular Hemorrhagic	21 (.27%)
Changes In Physical Activity	20 (.26%)
Nervous System Neoplasms Malignant ...	19 (.25%)
Hepatic And Hepatobiliary	18 (.24%)
Skin Appendage Conditions	18 (.24%)
Musculoskeletal And Connective Tiss...	17 (.22%)
Upper Respiratory Tract Disorders	17 (.22%)
Gastrointestinal Motility And Defec...	16 (.21%)
Cranial Nerve Disorders	15 (.2%)
Oral Soft Tissue Conditions	15 (.2%)
Electrolyte And Fluid Balance Condi...	14 (.18%)
Heart Failures	14 (.18%)
Hepatobiliary	13 (.17%)
Viral Infectious	13 (.17%)
Bone And Joint Therapeutic Procedur...	12 (.16%)
Cardiac Disorder Signs	12 (.16%)
Maternal Complications Of Pregnancy	12 (.16%)
Pregnancy, Labour, Delivery And Pos...	12 (.16%)
Psychiatric	12 (.16%)
Angiedema And Urticaria	11 (.14%)
Embolism And Thrombosis	11 (.14%)
Investigations, Imaging And Histopa...	11 (.14%)
Maternal Complications Of Labour An...	11 (.14%)
Anterior Eye Structural Change, Dep...	10 (.13%)
Arteriosclerosis, Stenosis, Vascula...	10 (.13%)
Bone, Calcium, Magnesium And Phosph...	10 (.13%)
Disturbances In Thinking	10 (.13%)
Glucose Metabolism Disorders	10 (.13%)
Mood Disorders	10 (.13%)
Neonatal Respiratory	10 (.13%)
Renal Disorders	10 (.13%)
Retina, Choroid And Vitreous Hemorr...	10 (.13%)
Mental Impairment	9 (.12%)
Metastases	9 (.12%)
Neonatal And Perinatal Conditions	9 (.12%)
Postpartum And Puerperal	9 (.12%)
Psychiatric And Behavioural Symptom...	9 (.12%)
Central Nervous System Infections A...	8 (.1%)
Increased Intracranial Pressure And...	8 (.1%)
Depressed Mood Disorders	7 (.09%)
Gastrointestinal Conditions	7 (.09%)
Myocardial	7 (.09%)
Ocular Hemorrhages And Vascular	7 (.09%)
Schizophrenia And Other Psychotic	7 (.09%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sensorcaine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sensorcaine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.